Julien Taieb

Julien Taieb publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Julien Taieb sits on this spectrum.

Julien Taieb D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Julien Taieb sits on this spectrum.

Best Publications

• ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

  E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero

  3363
  Citations

• Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

  Christophe Louvet;R. Labianca;P. Hammel;G. Lledo

  1216
  Citations

• CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

  Francois Ghiringhelli;Cédric Ménard;Magali Terme;Caroline Flament

  1208
  Citations

• VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.

  Thibault Voron;Orianne Colussi;Elie Marcheteau;Simon Pernot

  1129
  Citations

• Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

  Valérie Vilgrain;Valérie Vilgrain;Helena Pereira;Eric Assenat;Boris Guiu

  917
  Citations

• Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

  Axel Grothey;Alberto F. Sobrero;Anthony F. Shields;Takayuki Yoshino

  898
  Citations

• FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

  Mustafa Suker;Berend R Beumer;Eran Sadot;Lysiane Marthey

  882
  Citations

• VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

  Magali Terme;Simon Pernot;Elie Marcheteau;Federico Sandoval

  700
  Citations

• A novel dendritic cell subset involved in tumor immunosurveillance.

  Julien Taieb;Nathalie Chaput;Cédric Ménard;Lionel Apetoh

  524
  Citations

• Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.

  Yung Jue Bang;E. Yañez Ruiz;E. Van Cutsem;K. W. Lee

  513
  Citations

• Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα

  Sophie Viaud;Sophie Viaud;Magali Terme;Magali Terme;Caroline Flament;Caroline Flament;Julien Taieb;Julien Taieb

  496
  Citations

• Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

  Eric Tartour;H. Pere;B. Maillere;M. Terme

  407
  Citations

• SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

  Guy A. van Hazel;Volker Heinemann;Navesh K. Sharma;Michael P.N. Findlay

  387
  Citations

• First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

  Harpreet S Wasan;Peter Gibbs;Navesh K Sharma;Julien Taieb

  383
  Citations

• Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue

  nathalie chaput;Samy Louafi;armelle Bardier;frederic charlotte

  347
  Citations

• Control of the immune response by pro-angiogenic factors.

  Thibault Voron;Elie Marcheteau;Simon Pernot;Orianne Colussi

  329
  Citations

• Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

  Julien Taieb;Josep Tabernero;Enrico Mini;Fabien Subtil

  300
  Citations

• Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.

  Charles S Fuchs;Kohei Shitara;Maria Di Bartolomeo;Sara Lonardi

  278
  Citations

• Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer.

  Maximilien Barret;Sami Antoun;Cécile Dalban;David Malka

  274
  Citations

• Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer

  Julien Taieb;Karine Le Malicot;Qian Shi;Frédérique Penault-Llorca

  264
  Citations